Sarepta Therapeutics, Inc. (SRPT)

22.05 -0.75 (-3.29%) USD  |  NASDAQ  |  Jan 15, 11:31
More

Sarepta Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Pfizer Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade